Sheller’s New Book Available, Read the First Chapter
NOW AVAILABLE ONLINE AND BY REQUEST AT YOUR LOCAL BOOKSTORE — Click here to buy the book online — PHARMAGEDDON: A Nation Betrayed A National Trial Lawyer Reveals an Industry Spinning Out of Control by Stephen A. Sheller, Esq. with New York Times best-selling author Sidney D. Kirkpatrick […]
News: Trials Begin October 2015
Sheller, P.C. law firm Risperdal cases continue, with trials beginning October, 2015. From the daily newspaper The Legal Intelligencer: “A second wave of trials in the Risperdal mass tort has been scheduled for October, and several more cases are gearing up for trials in the spring. Two trials against Janssen Pharmaceuticals, the maker of the […]
Invokana: FDA Warnings on SGLT2 Diabetes Drugs
Sheller, P.C. attorneys are investigating the newer class of diabetes drugs following FDA warnings. ABOUT THE DRUGS Invokana (Invokamet) is a relatively new SGLT2 inhibitor diabetes drug that is intended to be used in combination with diet and exercise to improve glycemic control and lower blood sugar in adults with type 2 diabetes mellitus. When […]
Sheller Spars With FDA
Lawyer Spars With FDA Over J&J Risperdal Court Documents by Ed Silverman, Pharmalot In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by the Risperdal antipsychotic, but cannot be released publicly due to a court order. The documents were sealed by a Philadelphia judge as […]
